Cargando…
Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer
Despite an aging population and underrepresentation of elderly patients in clinical trials, studies on elderly patients with metastatic pancreatic cancer are scarce. This study investigated the use of chemotherapy and survival in elderly patients with metastatic pancreatic cancer. From the Netherlan...
Autores principales: | van der Geest, Lydia G. M., Haj Mohammad, Nadia, Besselink, Marc G. H., Lemmens, Valery E. P. P., Portielje, Johanneke E. A., van Laarhoven, Hanneke W. M., Wilmink, J. (Hanneke) W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727341/ https://www.ncbi.nlm.nih.gov/pubmed/29035014 http://dx.doi.org/10.1002/cam4.1240 |
Ejemplares similares
-
The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population‐based analysis
por: Bakens, Maikel J., et al.
Publicado: (2016) -
Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population‐based study
por: van der Geest, Lydia G. M., et al.
Publicado: (2018) -
Delayed Versus Immediate Start of Chemotherapy in Asymptomatic Patients With Advanced Cancer: A Meta-Analysis
por: Augustinus, Simone, et al.
Publicado: (2023) -
Can we do without chemotherapy? A perspective on the combinations
nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and
esophageal cancer
por: Derks, Sarah, et al.
Publicado: (2022) -
Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study
por: Dijksterhuis, Willemieke P.M., et al.
Publicado: (2019)